For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Synlogic Operating Company, Inc.

USPTO Granted Patents = 24

% Expired Patents = 4.2

EPO Patents = 6

Forward Citations = 54

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Vincent M Isabella (21 out of 25 patents)

Dean Falb (19 out of 23 patents)

Jonathan W Kotula (19 out of 25 patents)

4. Paul F Miller (19 out of 23 patents)

5. Yves Millet (15 out of 17 patents)

6. Adam B Fisher (10 out of 11 patents)

7. Sarah Rowe (8 out of 9 patents)

8. Suman Machinani (6 out of 8 patents)

9. Saurabh Saha (2 out of 39 patents)

10. Ning Li (2 out of 2 patents)

11. Adam Lawrence (2 out of 2 patents)

12. Per Greisen (2 out of 2 patents)

13. Kristin Adolfsen (2 out of 2 patents)

14. James Spoonamore (2 out of 2 patents)

15. Jay Konieczka (2 out of 2 patents)

24 patents: Sort by Forward Citations

1. 12721882 - Enumeration of genetically engineered microorganisms by live cell counting techniques (2026-09-01),

2. 12703866 - ENGINEERED MICROORGANISMS (2026-08-11),

3. 12545886 - BACTERIA FOR THE TREATMENT OF DISORDERS (2026-02-10),

4. 12409195 - Bacteria engineered to reduce hyperphenylalaninemia (2025-09-09),

5. 12171790 - Microorganisms engineered to reduce hyperphenylalaninemia (2024-12-24),

6. 11896627 - Bacteria engineered to treat metabolic diseases (2024-02-13),

7. 11883439 - Bacteria engineered to treat a disease or disorder (2024-01-30),

8. 11879123 - Bacteria for the treatment of disorders (2024-01-23),

9. 11859189 - Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereof (2024-01-02),

10. 11845964 - Bacteria engineered to treat diseases associated with hyperammonemia (2023-12-19),

11. 11766463 - Microorganisms engineered to reduce hyperphenylalaninemia (2023-09-26),

12. 11723932 - Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells (2023-08-15),

13. 11685925 - Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier (2023-06-27),

14. 11618894 - Bacteria engineered to reduce hyperphenylalaninemia (2023-04-04),

15. 11471494 - Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells (2022-10-18),

Synlogic is pioneering the development of a novel class of Living Medicines, Synthetic Biotic medicines, based on its proprietary drug discovery and development platform. Synlogic's pipeline includes Synthetic Biotic-based approaches for the treatment of rare genetic diseases, metabolic diseases, and cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

24 Patents

#114 in Cambridge, MA

#829 in Massachusetts

#13,840 in US

#26,551 in the World

Cambridge, MA, United States of America

Synlogic Operating Company, Inc.

Forward Citations = 54

32 inventors:

Vincent M Isabella (21 out of 25 patents)

Dean Falb (19 out of 23 patents)

Jonathan W Kotula (19 out of 25 patents)

4. Paul F Miller (19 out of 23 patents)

5. Yves Millet (15 out of 17 patents)

Please report any incorrect information to [email protected]

Loading…